Macrophage presence and phenotype are critical determinants of the healing response following injury. Downregulation of the pro-inflammatory macrophage phenotype has been associated with the therapeutic use of bioscaffolds composed of extracellular matrix (ECM), but phenotypic characterization of macrophages has typically been limited to small number of nonspecific cell surface markers or expressed proteins. The present study determined the response of both primary murine bone marrow derived macrophages (BMDM) and a transformed human mononuclear cell line (THP-1 cells) to degradation products of two different, commonly used ECM bioscaffolds; urinary bladder matrix (UBM-ECM) and small intestinal submucosa (SIS-ECM).
Introduction:
Biologic scaffold materials composed of extracellular matrix (ECM) have been used in both preclinical and clinical studies to facilitate the functional reconstruction of soft tissues including the esophagus [1] , skeletal muscle [2] , and myocardium [3] , among others [4] [5] [6] . Results of such studies have varied from excellent to unacceptable [7] , and the reasons for disparate results have been attributed to variables such as the methods used to decellularize source tissues [8, 9] , the use of chemical crosslinking agents that inhibit scaffold degradation [10] , and other factors [11, 12] . Arguably the most important mechanism by which ECM bioscaffolds influence tissue remodeling and functional outcome is the modulation of macrophage phenotype [13] . In fact, the ratio of M2-like/MIL-4 (regulatory/anti-inflammatory) to M1-like/MIFN+LPS (pro-inflammatory) macrophages has been shown to be a predictor of favorable outcomes in multiple studies [14] [15] [16] [17] .
Macrophages have long been recognized as phagocytes with pro-inflammatory and cytotoxic functions. However, it is now understood that these cells also play essential roles in the resolution of inflammation [18, 19] , normal tissue development [20] , and in blastemal-based epimorphic regeneration in species such as the axolotyl [21] . These "non-classical" macrophage activities are increasingly tied to shifts in the balance of M1:M2 macrophages participating in the host inflammatory reaction. While the description of macrophages as having an M1 or M2 phenotype is operationally simple and facilitates discussion, supra-physiologic amounts of signaling molecules such as cytokines, toll-like receptor agonists, and growth factors have been used in-vitro to induce these extremes of pro-inflammatory or anti-inflammatory phenotype [22] [23] [24] . However, such conditions do not mimic the in-vivo complexity of macrophage activation. In fact, virtually any stimulus will likely elicit a macrophage phenotype that exists somewhere between the extremes.
The macrophage response to biomaterials is a critical predictor of downstream success or failure with respect to clinical outcomes. Though there is now widespread recognition of the heterogeneity and plasticity of macrophage phenotype, most studies evaluating / describing the macrophage response to a biomaterial have included only single-marker methods followed by conclusive statements regarding cell phenotype. The present manuscript reviews the macrophage response to biologic scaffold materials, particularly those derived from mammalian extracellular matrix.
Given the diversity and broad scope of endogenous signaling molecules resident within extracellular matrix (e.g., growth factors, cytokines, cryptic peptides and miRNA), and the widespread clinical use of ECM bioscaffolds in tissue reconstruction, the "Mecm" phenotype is characterized in the present study. Recognizing the limitations of only a single cell property as a defining identifier of macrophage phenotype, several parameters are evaluated including transcription factor profile, gene expression, protein expression, cell surface markers and functional properties. ECM bioscaffolds derived from two separate tissue sources (porcine small intestine and urinary bladder) are used to activate two macrophage populations that are commonly used for such studies: primary mouse bone marrow derived macrophages and THP-1 cells (a human mononuclear cell line). To further evaluate macrophage responses to ECM signaling molecules, the activation state of the cells at the time of ECM stimulation is considered.
Specifically, both naive macrophages and macrophages that have been activated with IFNγ+LPS are used in the present study.
Results
The terminology used to describe various states of macrophage activation (often referred to as "polarization") has contributed to potentially misleading conclusions regarding the role of macrophages in various physiologic and pathologic processes. For example, macrophages have been identified as M1 (pro-inflammatory) or M2 (anti-inflammatory), or given labels such as "regulatory" based upon selected surface markers or associated effector molecules.
Recommendations for standard nomenclature based upon definition of the activator were published in 2014 [25] , and this terminology will be used herein whenever possible (e.g., MIFN+LPS
and MIL-4). Macrophages stimulated with solubilized extracellular matrix (ECM) will be designated as MECM (MUBM-ECM and MSIS-ECM).
MECM has a distinct gene expression profile
Human THP-1 monocytes and mouse bone marrow (BMDM) were differentiated into macrophages to generate an M phenotype. M macrophages were then treated for 24h with IFN+LPS to establish an MIFN+LPS phenotype, IL-4 to establish an MIL-4 phenotype, or either UBM-ECM or SIS-ECM to establish an MECM (MUBM-ECM / MSIS-ECM) phenotype. In a separate experiment, M macrophages were challenged with IFN+LPS for 6 hours followed by a 24 hour treatment with UBM or SIS. Downstream analyses included: 1) Gene expression of 30 commonly investigated macrophage activation markers, surface markers, cytokines, transcription factors and metabolic markers; 2) Protein expression of the most highly regulated markers; and 3) macrophage function as assessed by phagocytosis and nitric oxide production (Supplementary figure1).
Thirty commonly used macrophage markers of activation, including surface markers, cytokines, transcription factors, and metabolic markers were analyzed by qPCR to better understand the gene expression signature of treated macrophages. Gene expression data are displayed as a heatmap in Figure 1 . Clear differences between the gene expression signature of THP-1 macrophages and BMDM are shown. Exposure of THP-1 macrophages to IFN+LPS resulted in an increase in almost the entire gene panel, while changes following exposure to IL-4 were relatively mild. In contrast, exposure to either UBM-ECM or SIS-ECM degradation products resulted in only minor changes in gene expression ( Figure 1A ).
Exposure of BMDM to IFN+LPS or IL-4 led to substantial changes in gene expression with contrasting profiles. The gene expression profile generated by exposure to UBM-ECM differed from that generated by exposure to SIS-ECM but there were areas of overlap. Notably, IFN+LPS and UBM-ECM treated BMDMs have a similar gene expression profile ( Figure 1B ).
When THP-1 macrophages were challenged with IFN+LPS for 6 hours followed by exposure to UBM-ECM or SIS-ECM for an additional 24 hours, no major changes in gene expression were observed ( Figure 1A ). However, there was a significant change in the gene expression signature in BMDM ( Figure 1B ). In addition to the different response between the two macrophage populations, there were also clear differences between UBM-ECM and SIS-ECM treatment groups post-cytokine treatment. Both UBM-ECM and SIS-ECM treatment groups showed a decrease in the transcription factor gene expression cluster, particularly when the cells were pre-treated with IFN+LPS. Gene expression values were normalized to those of untreated macrophages (M).
IFN+LPS activated macrophages were normalized to IFN+LPS followed by media treatment.
Principal component analysis (PCA) was conducted to identify the dominant members of the transcriptional signature associated with the test groups for further evaluation of downstream protein expression. BMDM and THP-1 macrophages treated for 24 hours with cytokines or ECM degradation products were scored and visually clustered by PCA. For THP-1 macrophages, CD206, KLF4 and TGM2 were found to be the genes most associated with IL-4 activation, and TNF, STAT1 and IRF3 were associated with IFN+LPS activation ( Figure 1C ). The BMDM showed Fizz-1, KLF-4 and Arg1 as the most differentially expressed genes associated with IL-4 activation, and TNF, STAT1 and iNOS were the most highly regulated genes with IFN+LPS activation ( Figure   1D ). Genes that are commonly cited in the literature as macrophage activation markers, and the genes identified in PCA data output, were chosen for further downstream protein analyses.
ECM degradation products and IL-4 promote similar protein expression profile
Protein expression was evaluated by western blot analysis and immunofluorescent labeling. THP-1 macrophages activated for 24 hours with UBM-ECM or SIS-ECM induced TGM2 and CD206 (MIL-4 associated markers). However, no changes were noted in the MIFN+LPS associated marker TNFα and only a mild change in iNOS expression with SIS-ECM activation. CD11b was used as a pan macrophage control marker for THP-1 macrophages (Figure 2A ). Macrophages activated with IFN+LPS followed by exposure to ECM degradation products showed a similar trend to the 24 hours treatment groups. When THP-1 macrophages were exposed to either UBM-ECM or SIS-ECM following activation with INF+LPS, both ECMs induced TGM2 and CD206 positive cells.
UBM-ECM and SIS-ECM both caused a reduction in iNOS expression by THP-1 macrophages that had been activated with IFN LPS. However, both UBM-ECM and SIS-ECM induced TNF positive cells when macrophages were activated with IFN+LPS ( Figure 2A ).
BMDM show Fizz-1 and Arg1 (MIL-4 associated markers in mice) expression after activation with UBM-ECM and SIS-ECM for 24 hours. In addition, BMDM were positive for the MIFN+LPS associated marker TNF after exposure to ECM degradation products, but were not positive for iNOS. F4/80 was used as a pan macrophage control marker for BMDM ( Figure 2C) . Similarly, macrophages activated with IFN+LPS followed by treatment with ECM degradation products showed enhanced Fizz-1 expression, but not enhanced Arg1 expression. Interestingly, both UBM-ECM and SIS-ECM inhibited iNOS expression and enhanced TNF expression after pre-activation with IFN+LPS.
Western blot analysis was used to determine relative protein expression of the specified genes that showed the greatest change in activity in response to specific treatments. For the MIFN+LPS associated markers, the THP-1 macrophages activated for 24 hours with UBM-ECM or SIS-ECM showed that the amount of STAT1 was comparable to that of M and MIL-4 cells, and significantly lower than that of the MIFN+LPS cells. No changes were noted in TNF and IRF3 ( Figure 2B ).
For the MIL-4 associated markers, TGM2 and KL4 protein expression were increased after IL-4 activation. No significant changes were found between the MECM groups and the M and MIFN+LPS phenotypes. When macrophages were first activated IFN+LPS, followed by exposure to SIS-ECM, a decrease in KLF4 protein expression was noted ( Figure 2B ). BMDM exposed to UBM-ECM or SIS-ECM degradation products show similar findings to THP-1 macrophages with some small differences. For example, BMDM activated by 24h exposure to UBM-ECM showed increased expression of STAT1 to a level similar to that of the MIFN+LPS treatment group, which was not seen in the THP-1 groups. However, in both populations of macrophages, no changes were noted in TNF expression levels ( Figure 2D) . Notably, an increase in iNOS expression was found only in the BMDM MIFN+LPS group. When macrophages were activated with IFN+LPS followed by UBM or SIS treatment, no changes were noted in iNOS and 
ECM degradation products affect macrophage functional activity
THP1 macrophages showed low levels of phagocytosis across all tested conditions. Cytokine treatment did not significantly enhance the phagocytic function of THP1 macrophages. However, UBM-ECM activation alone caused an increase in THP1 phagocytosis ( Figure 3A) . BMDM showed measurable basal phagocytic function. Phagocytosis by BMDM increased with IFN+LPS and no notable changes were detected following IL-4 activation ( Figure 3B ). Similar to the THP-1 macrophages, UBM-ECM activation resulted in an increase in phagocytosis. In both BMDM and THp1 macrophages, activation with IFN+LPS for 6h prior to 24h exposure to UBM-ECM or SIS-ECM did not affect the cells' phagocytic ability. THP1 macrophages did not produce nitric oxide (NO) in response to IFN+LPS or IL-4 stimulus. However, UBM treatment did show a slight increase in NO production. Interestingly, THP-1 macrophages challenged with IFN+LPS followed by UBM-ECM exposure did show a significant increase in NO production, but such changes were not observed with SIS-ECM exposure ( Figure 3C ). In BMDM, NO production increased following IFN+LPS. BMDM exposed to SIS or UBM alone had a slight increase in NO production. IFN+LPS activation followed by either UBM-ECM or SIS-ECM enhanced or prolonged cytokine effects compared to media controls ( Figure 3D ).
Material and Methods
The present study determined macrophage phenotype following exposure to degradation products derived from ECM bioscaffolds. Two macrophage populations commonly used in invitro studies examined: human THP-1 monocytes [American Type Culture Collection (ATCC)] and murine bone marrow derived macrophages. A comprehensive characterization of macrophage cell surface markers, gene expression, protein content, phagocytic capacity, and nitric oxide production was conducted. Based on previous studies, more than 30 different surface markers, transcription factors, cytokines and metabolic markers were selected to evaluate the ECM-induced macrophage phenotype, termed MECM. In addition, the production of proteins selected based upon PCA analysis was determined by western blotting and immunolabeling. Lastly, macrophage phagocytic activity and nitric oxide production posttreatment was determined. The variety of methods used to assess the changes in macrophage phenotype are described below.
Preparation of ECM Bioscaffolds
Porcine urinary bladders from market weight (approximately 110 kg) animals were acquired from Tissue Source, LLC. (Lafayette, Indiana, USA). Urinary bladder matrix (UBM-ECM) was prepared by decellularization using mechanical and chemical methods as previously reported [26] . Briefly, the tunica serosa, tunica muscularis externa, tunica submucosa, and tunica muscularis mucosa were mechanically removed. The luminal urothelial cells of the tunica mucosa were dissociated by washing with sterile water. The remaining tissue consisting of basement membrane and subjacent tunica propria of the tunica mucosa was decellularized by agitation in 0.1% peracetic acid with 4% ethanol for 2 hours at 300 rpm. The tissue was then extensively rinsed with phosphate-buffered saline (PBS) and sterile water. The UBM-ECM was then lyophilized and milled into particulate form using a Wiley Mill with a #60 mesh screen.
Preparation of SIS-ECM has been previously described [27] . Briefly, jejunum was harvested from market weight pigs and split longitudinally. The superficial layers of the tunica mucosa were mechanically removed. Likewise, the tunica serosa and tunica muscularis externa, tunica submucosa, and tunica muscularis mucosa were mechanically removed, leaving the tunica submucosa and basilar portions of the tunica mucosa. Decellularization and disinfection of the tissue occurred by agitation in 0.1% peracetic acid with 4% ethanol for 2 hours at 300 rpm. The tissue was then extensively rinsed with phosphate-buffered saline (PBS) and sterile water. The SIS-ECM was then lyophilized and milled into particulate form using a Wiley Mill with a #60 mesh screen.
Derivation of ECM Degradation Products
UBM-ECM and SIS-ECM were enzymatically degraded as previously described [28] with pepsin from porcine stomach mucosa (MP Biomedicals) by mixing lyophilized, powdered UBM-ECM (10 mg/mL) and pepsin (1 mg/mL) in 0.01 M HCl (pH 2.0). This solution was stirred at room temperature for 48 hours. After stirring, the UBM slurry was neutralized to a pH of 7.4 in 1× PBS (137 mM NaCl, 2.7 mM KCl, 12 mM Phosphate, Fisher Scientific, Waltham, MA) to inactivate the pepsin.
Macrophage culture
THP-1 human monocytes (TIB-202™) were obtained from the American Tissue Culture Collection (ATCC, Manassas, VA) and maintained in RPMI, 10% FBS, 1% penicillin/streptomycin, and 50 uM of 2-Mercaptoethanol in a humidified atmosphere at 37 °C with 5% CO2. Two million THP-1 cells were plated with 320 nM phorbol 12-myristate 13-acetate (PMA) to induce differentiation into macrophages. After 24 hours adherent macrophages were washed in PBS and placed in fresh media, followed by 72 hours incubation in fresh media to acquiesce. This protocol has been shown to result in a phenotype that is nearly indistinguishable from human peripheral blood macrophages [28] .
Murine bone marrow derived macrophages (BMDM) were isolated as previously described [29] .
Briefly, the tibia and femur were isolated from adult, female 6-8-week old C57bl/6 mice obtained from Jackson Laboratories (Bar Harbor, ME). Bones were kept on ice and rinsed in a sterile dish containing macrophage complete medium consisting of DMEM (Gibco, Grand Island, NY), 10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA), 10% L929 supernatant, 0.1% betamercaptoethanol (Gibco), 100 U/ml penicillin, 100 ug/ml streptomyocin, 10 mM non-essential amino acids (Gibco), and 10 mM hepes buffer. In a sterile environment, the ends of each bone were transected and the marrow cavity flushed with complete medium using a 30-gauge needle. Harvested cells were washed and plated at 10 6 cell/ml, and allowed to differentiate into macrophages for 7 days at 37 °C, 5% CO2 with complete media changes every 48 h resulting in naïve macrophages.
Macrophage activation
Macrophages were activated for 24 hours with one of the following: (1) 20 ng/ml IFNγ and 100 ng/ml LPS to promote an MIFN+LPS phenotype, (2) 20 ng/ml IL-4 to promote an MIL-4 phenotype, or [30] 250 ug/ml of UBM-ECM, or SIS-ECM to promote an MECM phenotype. An equivalent concentration of pepsin was used as control buffer. In a separate group, macrophages were just activated with IFN+LPS for 6 hours, as described above, and then exposed to UBM-ECM or SIS-ECM for 24 hours. After the incubation period at 37 °C, cells were washed with sterile PBS and fixed with 2% paraformaldehyde for immunolabeling or harvested with TRIZOL/RIPA buffer for RNA/Protein assessment, respectively. Cells were also assessed for phagocytosis and nitric oxide production.
RNA isolation and cDNA synthesis
Cellular RNA was isolated using the miRNeasy Mini kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. Reverse transcriptase from RNA to cDNA was performed via high capacity RT kit (ABI, Foster City, CA) according to the manufacturer's instructions.
quantitative polymerase chain reaction (PCR)
Sybr Green gene expression assays (ABI, Foster City, CA) were used to determine the relative expression levels of THP-1: iNOS, TNF, STAT1, STAT2, STAT5, IRF3, IRF4, IRF5, IL1RN, CD206, TGM2, STAT3, STAT6, KLF4, KLF6, PPAR. BFKBF3, GLUT1, HIF1a, PGK1, LDHA, HK3, PDK4, RPIA, PPAR, G6PC3 and PCK2. For BMDM gene expression levels: inos, tnf, stat1, stat2, stat5, irf3, irf4, irf5, il1rn, cd206, tgm2, stat3, stat6, klf4, klf6, fizz-1, arg1, bfkbf3, glut1, hif1a, hk3, pgk1, pdk4, rpia, ldha, pck1, pck2, g6pc3 and ppar . Results were analyzed by the ΔΔCt method using β-glucuronidase (β -GUS) control for human, and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) for mouse, to normalize the results. Fold change was calculated taking untreated as the baseline. Results are displayed in a heat map format created by Java Treeview.
Gene description can be found in Table 1 : 
IRF3
interferon regulatory factor 3 Like IRF5, interferon regulatory factor 3 is found in an inactive cytoplasmic form that upon serine/threonine phosphorylation forms a complex with CREBBP. Signaling through the TRIF adaptor pathway activates IRF3, leading to the expression and secretion of type I interferon, such as IFNα and IFNβ [22, 31] .
IRF4
interferon regulatory factor 4
Interferon regulatory factor 4 is found in an inactive cytoplasmic form that upon serine/threonine phosphorylation forms a complex with CREBBP. IRF4 has been identified as a key transcription factor that controls M2 macrophage polarization [31, 40] .
IRF5
interferon regulatory factor 5
Interferon regulatory factor 5 is found in an inactive state in the cytoplasm. Upon serine/threonine phosphorylation, IRF5 forms a complex with CREBBP. IRF5 acts as a molecular switch influencing whether macrophages promote or inhibit inflammation. IRF5 is required for optimal Akt2 activation, which increases expression of glycolytic pathway genes and HIF1A as well as pro-inflammatory cytokines and M1 polarization [31, 41] .
KLF4
Kruppel like factor 4 
STAT3
signal transducer and activator of transcription 3
Upon stimulation with cytokines and growth factors, STAT family members are phosphorylated to form homo-or heterodimers that translocate to the cell nucleus and act as transcription activators. IL-4 and IFN-γ, together with TLR stimulation, upregulate SOCS1 (31) and SOCS3 (32) , which inhibit STAT1 and STAT3, respectively [22, 31] .
Macrophage Immunolabeling
To determine macrophage surface marker expression profiles, activated cells were fixed with 2% CellProfiler (Broad Institute, Cambridge, MA, USA) was used to quantify images.
Western blot
Western blots were performed on treated macrophage cell lysates. Cell lysates were boiled at 95 °C for 5 min and electrophoresed on 4-20% gradient acrylamide gels. Specifically, 10 ug of protein was loaded into each well. Separated proteins were transferred to Polyvinylidene difluoride (PVDF) membranes (Bio-rad) using a wet transfer set up. Following transfer, membranes were then blocked for 45 min with Pierce protein-free blocking buffer (Pierce Chemical, Rockford, IL) and incubated overnight with the following primary antibodies: iNOS, TNF-, STAT1, IRF3 CD206, TGM2, and KLF4, for THPI and iNOS, TNF-, STAT1, Arg1, Fizz-1 and KLF4 for BMDM. Membranes were washed three times for 15 min in 1X PBS, before and after they were incubated with appropriate secondary antibody. The washed membranes were exposed to chemiluminescent substrate (Bio-Rad) and then visualized using chemidoc touch instrument (Bio-Rad). Image Densitometry was evaluated using the shareware ImageJ (http://rsbweb.nih.gov/ij/index.html).
Nitric Oxide Quantification
Bone marrow macrophages and THP-1 cells were cultured and treated as previously described above. Following treatment, the supernatant from the wells was transferred to another plate and frozen at -80°C. The supernatant was thawed then 50 μL was added to another plate. 50 μL of standards consisting of sodium nitrite from 100 μM to 1.56 μM in a 1:2 serial dilution were added to the plate. The wells were treated with 50 μL of 1% sulfanilamide in 5% phosphoric acid for 10 minutes. Then 50 μL of 0.1% N-1-napthylethylenediamine [NED] dihydrochloride in water was added for an additional 10 minutes. The wells were then read at 540 nm and compared to the standard curve. Readings were normalized to the amount of DAPI-stained cells in each well as quantified by Cell Profiler.
Phagocytosis Assay
Following activation, cells were incubated with Vybrant Phagocytosis Kit FITC-labeled E. Coli beads for 2 hours. Wells were then washed once with 1XPBS and fixed with 2% paraformaldehyde for 30 minutes. Wells were washed 3 times with 1X PBS then stained with DAPI for 10 minutes and washed again three times with 1X PBS. Wells were imaged using an automated Live Cell Scope and quantified for mean intensity of the cells using Cell Profiler software. Mean intensity averages were calculated as percent changes from M0 naïve macrophage controls.
Discussion
The results of the present study show clearly that BMDM and THP-1 macrophages respond differently to the same stimulus. The phenotype of these two macrophage populations following activation by an ECM scaffold can appear very similar or vastly different depending upon whether gene expression, protein expression, or surface markers are evaluated.
Furthermore, although SIS-ECM and UBM-ECM have both been associated with constructive, functional tissue remodeling outcomes in both pre-clinical animal models and in clinical applications in man, the macrophage phenotype resulting from activation with each ECM is distinct from those elicited by activation with either IFNγ+ LPS or IL-4. Finally, following activation by IFNγ + LPS, macrophages then exposed to degradation products of both ECM bioscaffolds show a marked downregulation of genes that are typically associated with an inflammatory profile.
ECM bioscaffolds typically promote a favorable tissue remodeling response when used to treat various types of soft tissue injury. This response includes the recruitment of endogenous stem cells, angiogenesis, and dampening of the inflammatory response. This pro-healing response has been attributed, in large part, to the effect of ECM on macrophage phenotype [8] . The objective of the present study was to comprehensively characterize the MECM phenotype. The source of macrophages used in this study; specifically, primary cells isolated from murine bone marrow (i.e., BMDM) and a transformed human mononuclear cell line (i.e., THP-1) are commonly used in studies to evaluate macrophage phenotype and behavior, and therefore the results are of interest to the field of macrophage biology [56, 57] . Since conclusions from such studies can have far-reaching implications, it is important to understand the effect of the source of macrophages upon study results.
BMDM and THP-1 macrophages differentially respond to the same stimulus
There was a clear difference between the response of BMDM and THP-1 macrophages to both canonical stimuli such as IFNy + LPS or IL-4 as well as to SIS-ECM and UBM-ECM degradation products. Gene expression analyses showed that THP-1 macrophages were not significantly affected by activation with IL-4, SIS-ECM, or UBM-ECM exposure, but there was a notable increase in most of the evaluated genes following activation by IFNγ+ LPS. This response was in stark contrast to the BMDM gene expression signature that showed significant changes to all of the applied stimuli. We hypothesize that these changes are likely due to the endogenous differences between a cell line (i.e., THP-1) and primary cells (i.e., BMDM). Another difference between the two macrophage populations was the difference in macrophage function following activation. THP-1 macrophages were associated with very little nitric oxide (NO) production and phagocytosis regardless of their stimulus, whereas BMDM showed an increase in NO production and phagocytic activity when stimulated with IFNy + LPS similar to the response one would expect in vivo following exposure to a pro-inflammatory stimulus.
The mechanism(s) by which macrophages are able to phagocytose and produce nitric oxide are largely unknown. However, the activation state of macrophages and the effect on cell function has been described [58, 59] and suggests that an increase in ARG1 and decrease in iNOS gene expression levels (as seen in Figure 1 ) may lead to the decrease seen in phagocytic activity [58] .
Overall, the "M1-like" macrophages are more associated with phagocytosis and nitric oxide production than their "M2-like" counterparts. The present study shows that the challenged MECM phenotype has reduced phagocytic activity (associated with "M2-like") and an increase in nitric oxide production (associated with "M1-like"). This finding is further evidence of the complexity and plasticity of macrophages and the unique MECM phenotype compared to canonical controls.
The collective findings of the present study suggest that the in vitro response of BMDM respond more similarly than THP1 cells with respect to the behavior observed by macrophages in preclinical animal models and clinical studies that have examined ECM-mediated tissue remodeling [10, 14] . Though there are multiple cell types utilized to investigate the in vitro macrophage behavior, THP-1 macrophages were chosen because of their widespread use in the immunology and regenerative medicine field [1] [2] [3] [4] . The new data presented herein clearly show that the THP-1 derived macrophages have a restrictive phagocytic and nitric oxide production ability, thereby limiting "typical" macrophage functionality. There are also marked differences in gene expression when compared to BMDM. Future work may benefit from using the results reported herein as a comparative dada case for alternative cell types that may be used to evaluate macrophage behavior in-vitro.
SIS-ECM and UBM-ECM induce similar but distinct macrophage phenotypes
Both SIS-ECM and UBM-ECM have been associated with an increased bioscaffold-localized M2:M1 ratio in preclinical animal studies, and a constructive, functional tissue remodeling response, but the macrophage phenotype has typically been characterized based upon a small number of cell markers [62, 63] . In the present study, gene expression analysis of resting BMDM
showed that the macrophage response to SIS-ECM is similar to that of IL-4 activation. BMDM exposed to UBM-ECM, in contrast, show a gene expression profile that is similar to that of the However, when macrophages are first activated with a pro-inflammatory stimulus, both SIS-ECM and UBM-ECM down-regulate markers associated with a classic inflammatory response including iNOS, STAT1, STAT2, and KLF6 which is consistent with observed in vivo events. Both MSIS-ECM and MUBM-ECM augment nitric oxide production after IFNy+LPS stimulus in vitro, but the MUBM-ECM phenotype is associated with an increased phagocytic capability compared to the MSIS-ECM
phenotype. The present work shows that the "MECM" phenotype differs depending upon the ECM source tissue and is perhaps more accurately defined as "M'source-tissue'-ECM", for example "MSIS-ECM" or "MUBM-ECM".
The effect of ECM upon naive macrophages vs. MIFNγ+LPS
Following injury, ECM scaffolds are applied to a soft tissue site following injury. The macrophages that interact with the ECM scaffold are likely in an activated state rather than a resting state. In an attempt to mimic this scenario, the present study evaluated the phenotypic response of both resting macrophages and IFNγ+LPS activated macrophages. There were clear differences between the response of "resting" macrophages and "pre-activated" macrophages to ECM degradation products. As previously mentioned, the MSIS-ECM and the MUBM-ECM phenotypes are distinct from each other when naive macrophages are exposed to degradation products of ECM.
However, MIFNy+LPS activated macrophages respond similarly to both ECM sources with a downregulation of inflammatory markers. The results of the present study show that the activation state of macrophages can influence the phenotypic response to subsequent stimuli. These findings are consistent with those of in vivo studies that show ECM bioscaffolds promote an antiinflammatory macrophage phenotype with associated constructive and functional outcomes when utilized in response to injury or disease [8, 82] . The MIFNy+LPS may better represent a physiologic macrophage's state in response to injury, when investigating the in vitro response to a given stimulus.
Conclusions
The present study provides a comprehensive analysis of the macrophage phenotype associated with exposure to ECM scaffolds derived from the small intestine and urinary bladder.
The results of the study demonstrate that the phenotype associated with both SIS-ECM and UBM-ECM is distinct from the canonical MIFNy+LPS and MIL-4 phenotypes. Of note, there were also differences observed between SIS-ECM and UBM-ECM, suggesting that the microenvironment of the source tissue from which the ECM bioscaffold is produced also plays a significant role in determining patterns of macrophage activation. Lastly, it is noted that there are challenges and isolated from C57bl/6 mice and cultured in media supplemented with macrophage-colonystimulating-factor (MCSF) to derive macrophages. "M1-like" macrophages, "M2-like" macrophages, and ECM-activated macrophages were derived as described above.
Additionally, "M1-like" macrophages were exposed to UBM-ECM or SIS-ECM degradation products as before. Immunolabeling results were further evaluated using western-blot analysis of the STAT1, Arginase, Fizz, iNOS, and TNF markers (bottom Panel). Scale bar is equal to 200 m. was assessed using the Greiss reagent system on macrophage supernatants following treatment. 
